For research use only. Not for therapeutic Use.
Sugammadex(CAT: I009639) is an agent for reversal of neuromuscular blockade by the agent rocuronium in general anaesthesia. It is the first selective relaxant binding agent (SRBA). Sugammadex is a modified γ-cyclodextrin, with a lipophilic core and a hydrophilic periphery. This gamma cyclodextrin has been modified from its natural state by placing eight carboxyl thio ether groups at the sixth carbon positions. These extensions extend the cavity size allowing greater encapsulation of the rocuronium molecule. These negatively charged extensions electrostatically bind to the quaternary nitrogen of the target as well as contribute to the aqueous nature of the cyclodextrin.
| Catalog Number | I009639 |
| CAS Number | 343306-71-8 |
| Synonyms | Org25969; Org-25969; Org 25969; 361LPM2T56; Sugammadex; trade name: Bridion.;6A,6B,6C,6D,6E,6F,6G,6H-octakis-S-(2-Carboxyethyl)-6A,6B,6C,6D,6E,6F,6G,6H-octathio-γ-cyclodextrin |
| Molecular Formula | C72H112O48S8 |
| Purity | ≥95% |
| Solubility | Soluble in DMSO, not in water |
| Storage | 0 - 4 °C for short term, or -20 °C for long term |
| Related CAS | 343306-79-6(Sodium salt) |
| InChI | InChI=1S/C72H112O48S8/c73-33(74)1-9-121-17-25-57-41(89)49(97)65(105-25)114-58-26(18-122-10-2-34(75)76)107-67(51(99)43(58)91)116-60-28(20-124-12-4-36(79)80)109-69(53(101)45(60)93)118-62-30(22-126-14-6-38(83)84)111-71(55(103)47(62)95)120-64-32(24-128-16-8-4 |
| InChIKey | WHRODDIHRRDWEW-XJDGUENZSA-N |
| SMILES | O[C@H]1[C@H](O)[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](O)[C@H](O[C@@H]4[C@@H](O)[C@H](O)[C@H](O[C@@H]5[C@@H](O)[C@H](O)[C@H](O6)C(CSCCC(O)=O)O5)C(CSCCC(O)=O)O4)C(CSCCC(O)=O)O3)C(CSCCC(O)=O)O2)C(CSCCC(O)=O)O[C@@H]1O[C@H]7[C@@H](O)[C@H]( |
| Reference | 1:A confirmed case of sugammadex-induced anaphylaxis in a UK hospital. O/’Donnell R, Hammond J, Soltanifar S.BMJ Case Rep. 2017 May 13;2017. pii: bcr-2017-220197. doi: 10.1136/bcr-2017-220197. PMID: 28501827 <br /> |
